argenx Bags $231M in Upsized U.S. IPO Post author:Sam Post published:December 13, 2017 Post category:BioPharma argenx increased the Offering from the initially filed offering size of $150 million. Source: BioSpace You Might Also Like Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017 Apricus Biosciences Announces Corporate Update And First Quarter 2017 Financial Results Conference Call May 3, 2017 STAAR Surgical Reports Fourth Quarter 2016 Results March 2, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017
Apricus Biosciences Announces Corporate Update And First Quarter 2017 Financial Results Conference Call May 3, 2017
